M. Nishio et al., BLOCKAGE BY TERFENADINE OF THE ADENOSINE-TRIPHOSPHATE (ATP)-SENSITIVEK+ CURRENT IN RABBIT VENTRICULAR MYOCYTES, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 293-300
We examined the blocking effects of terfenadine, an antihistaminic age
nt, on the ATP-sensitive K+ current (I-K,I-ATP) in rabbit ventricular
cells. I-K,I-ATP was induced by cromakalim or NaCN. Terfenadine blocke
d the I-K,I-ATP with an IC50 of 1.7 mu M at -10 mV. This blockage was
voltage dependent; depolarization induced a stronger blockage. Accordi
ng to the transmembrane electrical field model, terfenadine interacts
with the site located 15 to 18% from the cytoplasmic membrane surface.
In line with the assumption that the binding site is near the cytopla
smic surface, terfenadine applied to the cytoplasmic solution potently
inhibited the single-channel activity for I-K,I-ATP in the inside-out
configuration (IC50 0.19 mu M). In contrast, terfenadine applied to t
he external solution did not affect the channel activity in the cell-a
ttached configuration, but inhibited it when applied into the pipette.
The inhibition of the single channels by terfenadine was accompanied
by flickering of the channels. These findings suggest that 1) terfenad
ine blocks the ATP-sensitive K+ channel in the open state, 2) the bind
ing site is near the internal membrane surface and 3) terfenadine is p
oorly diffusible into the lipid biomembrane and accesses the binding s
ite via the hydrophilic pathway. Terfenadine also inhibited the transi
ent outward K+ current, inward rectifier K+ current and E4031-sensitiv
e rectifier K+ current. However, the inhibition of these repolarizatio
n currents by terfenadine at 1 mu M was not sufficient to prolong the
action potential duration significantly. Whereas, terfenadine (1 mu M)
prolonged the action potential duration which had been shortened by c
romakalim. Terfenadine may modify the ischemia-induced arrhythmias by
blocking I-K,I-ATP.